PD1 and PDL1 Inhibitors represent a groundbreaking class of immunotherapy drugs designed to combat various types of cancer. These innovative therapies work by bolstering the body's immune system, empowering it to recognize and attack tumor cells more effectively. By blocking the interactions between PD-1 and PD-L1, these inhibitors unleash the full potential of immune responses, allowing the...